Pediatric campylobacteriosis in northern Taiwan from 2003 to 2005
<p>Abstract</p> <p>Background</p> <p>There has been a marked increase in the incidence of, and concern regarding, human <it>Campylobacter jejuni </it>and <it>C. coli </it>infections worldwide during the last decade. As the highest infectious dise...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2008-10-01
|
| Series: | BMC Infectious Diseases |
| Online Access: | http://www.biomedcentral.com/1471-2334/8/151 |
| _version_ | 1818523688491810816 |
|---|---|
| author | Chiang Chuen-Sheue Wu Ho-Sheng Yang Ji-Rong Mu Jung-Jung |
| author_facet | Chiang Chuen-Sheue Wu Ho-Sheng Yang Ji-Rong Mu Jung-Jung |
| author_sort | Chiang Chuen-Sheue |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>There has been a marked increase in the incidence of, and concern regarding, human <it>Campylobacter jejuni </it>and <it>C. coli </it>infections worldwide during the last decade. As the highest infectious disease control apparatus in Taiwan, we aimed to describe the character of <it>Campylobacter </it>isolates from infected children, as well as basic information about the patients, from December 2003 to February 2005.</p> <p>Methods</p> <p>A total of 894 fecal specimens were collected by several clinics and hospitals from children who had diarrhea, followed by plating onto selective media. Drug susceptibility test of the isolates from these specimens were conducted by disc diffusion method and their serotypes were also studied using commercial antisera made in Japan.</p> <p>Results</p> <p>The isolation rate of <it>Campylobacter </it>during these 15 months was 6.8% and was higher in winter (11.1%) than in other seasons. <it>C. jejuni </it>was the most prevalent (95.1%) species in northern Taiwan, comparable to other developed countries. Among the 61 <it>Campylobacter </it>isolates, most were resistant to tetracycline (93.4%), nalidixic acid (91.8%), ciprofloxacin (90.2%), and ampicillin (85.5%). Erythromycin-resistant isolates represented 3.3% of all isolates, suggesting that this drug may be the first choice for treatment. The serotypes of the 61 isolates were demonstrated and only 41.4% were typable.</p> <p>Conclusion</p> <p>In this study, the Taiwan CDC provided an epidemiological analysis of <it>Campylobacter </it>infection, including the isolation rate, age, seasonal distribution, antimicrobial drug susceptibility patterns, and serotypes of the isolates from pediatric patients in northern Taiwan from 2003 to 2005.</p> |
| first_indexed | 2024-12-11T05:47:55Z |
| format | Article |
| id | doaj.art-c4298dbb83e14fca82b3b30b9a3e1456 |
| institution | Directory Open Access Journal |
| issn | 1471-2334 |
| language | English |
| last_indexed | 2024-12-11T05:47:55Z |
| publishDate | 2008-10-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Infectious Diseases |
| spelling | doaj.art-c4298dbb83e14fca82b3b30b9a3e14562022-12-22T01:18:54ZengBMCBMC Infectious Diseases1471-23342008-10-018115110.1186/1471-2334-8-151Pediatric campylobacteriosis in northern Taiwan from 2003 to 2005Chiang Chuen-SheueWu Ho-ShengYang Ji-RongMu Jung-Jung<p>Abstract</p> <p>Background</p> <p>There has been a marked increase in the incidence of, and concern regarding, human <it>Campylobacter jejuni </it>and <it>C. coli </it>infections worldwide during the last decade. As the highest infectious disease control apparatus in Taiwan, we aimed to describe the character of <it>Campylobacter </it>isolates from infected children, as well as basic information about the patients, from December 2003 to February 2005.</p> <p>Methods</p> <p>A total of 894 fecal specimens were collected by several clinics and hospitals from children who had diarrhea, followed by plating onto selective media. Drug susceptibility test of the isolates from these specimens were conducted by disc diffusion method and their serotypes were also studied using commercial antisera made in Japan.</p> <p>Results</p> <p>The isolation rate of <it>Campylobacter </it>during these 15 months was 6.8% and was higher in winter (11.1%) than in other seasons. <it>C. jejuni </it>was the most prevalent (95.1%) species in northern Taiwan, comparable to other developed countries. Among the 61 <it>Campylobacter </it>isolates, most were resistant to tetracycline (93.4%), nalidixic acid (91.8%), ciprofloxacin (90.2%), and ampicillin (85.5%). Erythromycin-resistant isolates represented 3.3% of all isolates, suggesting that this drug may be the first choice for treatment. The serotypes of the 61 isolates were demonstrated and only 41.4% were typable.</p> <p>Conclusion</p> <p>In this study, the Taiwan CDC provided an epidemiological analysis of <it>Campylobacter </it>infection, including the isolation rate, age, seasonal distribution, antimicrobial drug susceptibility patterns, and serotypes of the isolates from pediatric patients in northern Taiwan from 2003 to 2005.</p>http://www.biomedcentral.com/1471-2334/8/151 |
| spellingShingle | Chiang Chuen-Sheue Wu Ho-Sheng Yang Ji-Rong Mu Jung-Jung Pediatric campylobacteriosis in northern Taiwan from 2003 to 2005 BMC Infectious Diseases |
| title | Pediatric campylobacteriosis in northern Taiwan from 2003 to 2005 |
| title_full | Pediatric campylobacteriosis in northern Taiwan from 2003 to 2005 |
| title_fullStr | Pediatric campylobacteriosis in northern Taiwan from 2003 to 2005 |
| title_full_unstemmed | Pediatric campylobacteriosis in northern Taiwan from 2003 to 2005 |
| title_short | Pediatric campylobacteriosis in northern Taiwan from 2003 to 2005 |
| title_sort | pediatric campylobacteriosis in northern taiwan from 2003 to 2005 |
| url | http://www.biomedcentral.com/1471-2334/8/151 |
| work_keys_str_mv | AT chiangchuensheue pediatriccampylobacteriosisinnortherntaiwanfrom2003to2005 AT wuhosheng pediatriccampylobacteriosisinnortherntaiwanfrom2003to2005 AT yangjirong pediatriccampylobacteriosisinnortherntaiwanfrom2003to2005 AT mujungjung pediatriccampylobacteriosisinnortherntaiwanfrom2003to2005 |